Covered recipient · General Payments record
RODERICK DAVID EKMARK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,050.03
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $461.02 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $202.73 | 8 |
| Lilly USA, LLC | $88.39 | 5 |
| Acerta Pharma LLC | $63.02 | 4 |
| DEXCOM, INC. | $20.19 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.25 | 1 |
| Exact Sciences Corporation | $18.18 | 1 |
| PFIZER INC. | $17.68 | 1 |
| Amgen Inc. | $17.41 | 1 |
| GlaxoSmithKline, LLC. | $14.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.33 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103682291 | CMS |
| ABBVIE INC. | $27.34 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103682293 | CMS |
| ABBVIE INC. | $23.69 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103682295 | CMS |
| ABBVIE INC. | $12.61 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103682297 | CMS |
| ABBVIE INC. | $28.26 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103682299 | CMS |
| ABBVIE INC. | $29.21 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103682301 | CMS |
| ABBVIE INC. | $24.17 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103682303 | CMS |
| ABBVIE INC. | $33.12 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103682305 | CMS |
| Amgen Inc. | $17.41 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117547801 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.79 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105549283 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.62 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354506 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.62 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104617476 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.99 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105806432 | CMS |
| Dexcom, Inc. | $20.19 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153332123 | CMS |
| Exact Sciences Corporation | $18.18 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114646614 | CMS |
| GlaxoSmithKline, LLC. | $14.17 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116424047 | CMS |
| Lilly USA, LLC | $19.88 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135398899 | CMS |
| Lilly USA, LLC | $18.84 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135387993 | CMS |
| Lilly USA, LLC | $17.15 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135398901 | CMS |
| Lilly USA, LLC | $14.50 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135357402 | CMS |
| Lilly USA, LLC | $18.02 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135357404 | CMS |
| PFIZER INC. | $17.68 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132002187 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.25 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137538643 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.